Eight Roads Ventures

Eight Roads Ventures is a global venture capital firm and the proprietary investment arm of Fidelity International Limited (FIL). It targets technology-enabled companies across stages from early venture to growth and late-stage, with a focus on healthcare IT, information technology, software and services, fintech, consumer and enterprise technology, telecommunications, and related sectors. It operates internationally with offices in Europe (London) and Asia (Beijing, Shanghai, Hong Kong, Tokyo, Mumbai, Bengaluru) and partnerships in Israel, Singapore, and the United States, reflecting a broad geographic scope. It typically invests between modest seven-figures to tens of millions of dollars, seeks to lead or co-lead and often takes a board seat, supporting portfolio companies with strategic and operational expertise. The firm emphasizes long-standing partnerships and a hands-on approach, backed by FIL’s resources.

Umang Agarwal

Principal

Hiroki Ashida

Vice President

Daniel Auerbach

Senior Managing Partner and Head of Global Ventures

Vytautas Balsys

Partner

Helena Barman

Investor

Katy Barnett

Associate

Virginia Bassano

Vice President

Shirish Belapure

Venture Partner

Daniel Benjamin

Investor

Betty Cai

Partner

Ted Chua

Senior Partner

Lucile Cornet

Partner

Kevin Du

Senior Associate

Raj Dugar

Managing Partner, India

Martin Ericsson

Vice President

Tamina Fogelberg

Investor

Siddhant Gandhi

Associate

Elaine Gao

Senior Associate

Antonin Gury-Coupier

Investor

Davor Hebel

Managing Partner

April Hu

Vice President

Tao Huang

Principal

Tammy Huang

Senior Associate

Tao Huang

Principal

Allen Huo

Vice President

Abhishek Jain

Vice President

Deepak Kanvinde

Venture Partner

Michiko Kohyama

Vice President

Shinichiro Komoto

Partner

Kavish Kothari

Principal

Chintan Kothari

Partner

Thomas Lin

Vice President

Xin Liu

Partner

Weimin Liu Ph.D

Partner

Allen Liu

Senior Associate

Maneesh Menon

Principal

Sophie Meralli

Vice President

Chersy Miao

Principal

David Milstein

Managing Partner and Head of Japan

Junichi Murata

Partner

Jens Neisius

Vice President

Dan O'Toole

Vice President

Yosuke Ouchi

Principal

Alexandra Prescot

Investor

Delphine Qiu

Principal

Eyal Rabinovich

Investor

Laura Salesse

Investor

Fuga Sawada

Senior Associate

Shawn Shen

Partner

Sagar Sheth

Vice President

Lei Shi Ph.D

Partner

Arjun Singh

Senior Associate

Michael Stephanblome

Venture Partner

Liena Suzuki MD

Principal

Aditya Systla

Partner

Michael Treskow

Partner

Jarlon Tsang JD

Managing Partner and Head of China

Ashish Venkataramani

Partner

Ashish Venkataramani

Partner

Bo Wang

Senior Associate

He Wang

Vice President

Nancy Xu

Vice President

Cody Yin Ph.D

Partner

Yuan Yuan

Principal

Zang Jialun

Partner

Alston Zecha

Partner

Gordon Zhang

Partner

Zhang Yixiao

Executive Director

Haoming Zhang

Vice President

Feng Zhao Ph.D

Partner

Past deals in Series B

UGOKU

Series B in 2025
UGOKU is a provider of management of personal coaching service.

Swan

Series B in 2025
Swan is a Paris-based fintech company founded in 2019 that specializes in embedded finance through its Banking-as-a-Service platform. It enables businesses to create and manage bank accounts, issue cards, and generate IBANs seamlessly using straightforward APIs. Serving more than 60 clients across ten European countries, Swan handles over 200 million euros in transactions monthly. The company is staffed by over 100 employees, led by experts in the fintech sector. As a licensed financial institution regulated by the ACPR, Swan operates as a principal member of Mastercard, positioning itself as a key player in the European financial technology landscape.

Bhanzu

Series B in 2024
Bhanzu is a learning platform focused on mathematics education. It caters to students of all ages and grades, offering personalized learning experiences tailored to individual needs. The platform aims to foster careers in math and STEM fields by providing engaging educational content, including videos with tips on overcoming math anxiety for young learners.

AvenCell

Series B in 2024
Based on our deep science and focused on patients in need.

Everstage

Series B in 2024
Everstage is a no-code commissions automation platform founded in 2020 and based in Wilmington, Delaware. The company specializes in providing tools that streamline and enhance the management of sales commissions for customer-facing teams. Its platform offers real-time visibility and insights into performance, allowing businesses to create customized incentive structures while automating repetitive manual tasks. By delivering a transparent and gamified experience, Everstage helps organizations motivate their teams and improve overall performance.

Spry

Series B in 2024
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.

HERO Software

Series B in 2024
HERO Software provides cloud-based solutions aimed at enhancing office efficiency through digitization. Their platform enables companies to streamline their project management processes from initial contact through implementation and invoicing. Key features of the HERO app include customer and project management, appointment scheduling, construction site documentation, and task management, all designed to support field operations and client visits. The software helps businesses manage the entire order-processing cycle, monitor project progress, and handle planning and invoicing, ultimately improving communication and operational efficiency.

Engrail Therapeutics

Series B in 2024
Founded in 2019, Engrail Therapeutics is dedicated to developing and commercializing neuro drugs. Its primary focus is on treating diseases related to the nervous system. The company's flagship compound, ENX-101, is a preclinical modulator of a receptor for GABA, a neurotransmitter in the brain.

HiLabs

Series B in 2024
HiLabs is a developer of a healthcare data mining platform that aims to enhance data-driven decision-making within healthcare organizations. By leveraging artificial intelligence, HiLabs empowers employees to explore their data intuitively, uncover novel insights, and interact with data visualizations. The platform allows users to customize dashboards and generate new attributes, thus enhancing their ability to understand and utilize client health data effectively. HiLabs recognizes that healthcare providers possess vital domain knowledge but often lack the necessary tools to extract meaningful insights from their data. Through its innovative solutions, HiLabs bridges this gap, enabling healthcare organizations to harness their data more efficiently and improve overall decision-making processes.

EurekaBio

Series B in 2024
EurekaBio specializes in developing solutions for cancer immunotherapy, particularly in the realm of cell therapy. The company offers automated manufacturing equipment for cell therapies and a platform for vector production. By focusing on automation in medical equipment related to gene and cell therapy, EurekaBio aims to enhance the accuracy and efficiency of cancer treatments, ultimately benefiting patients in need of innovative therapeutic options.

La Fourche

Series B in 2024
La Fourche is an online platform dedicated to affordable organic consumption. It offers thousands of organic products with discounts up to 50%, helping families reduce their spending by up to €1,000 annually through a subscription model.

Xbit

Venture Round in 2024
Xbit is a developer of a shift management system that provides an innovative chatbot service for shop owners. This platform enables businesses to efficiently gather employee availability and create effective shift schedules. By addressing customer issues and needs, Xbit implements tailored solutions that enhance operational efficiency. The company focuses on optimizing business processes, allowing clients to reduce costs while maintaining high service quality through proper personnel allocation.

Micoworks

Series B in 2023
Micoworks is a marketing tool that facilitates communication and optimizes the customer experience through personalization.

Exponent Energy

Series B in 2023
Exponent Energy is a start-up dedicated to enhancing electric vehicle (EV) charging through innovative fast charging technology. The company specializes in battery-swapping infrastructure, aiming to provide a more efficient and cost-effective charging solution for EV users. It manufactures an integrated energy stack designed to minimize impedance build-up, which facilitates a smooth energy flow. This system includes a cohesive battery management system, battery pack, and charger that work in unison to streamline the charging process. By focusing on these advancements, Exponent Energy seeks to simplify and accelerate the energy replenishment for electric vehicles, catering to the growing demand for sustainable transportation solutions.

Eleos Health

Series B in 2023
Eleos Health offers automated healthcare technology solutions. Its AI-powered Speech-to-Insights system aids clinicians in making decisions swiftly, ensuring personalized, efficient, and cost-effective patient care.

Sonosemi Medical

Series B in 2023
Sonosemi Medical is a provider of medical devices that specializes in the development of pan-vascular active interventional products, diagnosis, and treatment solutions.

La Fourche

Series B in 2023
La Fourche is an online platform dedicated to affordable organic consumption. It offers thousands of organic products with discounts up to 50%, helping families reduce their spending by up to €1,000 annually through a subscription model.

Doceree

Series B in 2023
Doceree is a healthcare marketing technology company that provides a platform and solutions to help pharmaceutical and healthcare brands reach healthcare professionals. Its programmatic platform supports physician engagement and targeted advertising across physician networks, medical journals, telemedicine platforms, and relevant digital channels, delivering compliant, scalable messages. The platform uses artificial intelligence, data segmentation, and analytics to identify target healthcare professionals and optimize reach across global digital ecosystems. Doceree serves pharmaceutical brands, medical device brands, consumer health brands, hospitals, and media agencies, enabling access to physician-only environments and enabling compliant engagement at scale.

Cataya Bio

Series B in 2023
Cataya Bio (Shanghai) Co., Ltd. is a biotechnology company focused on developing synthetic biological products for various industries. Utilizing an advanced engineering biology platform, Cataya Bio engineers microbes and implements clean fermentation processes to produce high-purity products efficiently and sustainably. The company aims to facilitate the transition from petroleum-based materials to natural and sustainable raw materials, addressing critical global challenges such as environmental preservation, carbon emissions, and climate change. Through its innovative approach, Cataya Bio provides clients with effective solutions for sourcing raw materials that align with contemporary sustainability goals.

Raft

Series B in 2023
Raft is a smart logistics platform focused on automating the freight process to enhance control and visibility in logistics operations. It leverages artificial intelligence to analyze and act on incoming shipment data, significantly reducing the time operators spend on information retrieval and manual data entry. By automating various tasks, including accounts payable invoices, customs documentation, and shipping workflows, Raft enables freight forwarders and customs brokers to minimize manual work, thus improving accuracy and compliance. The platform's real-time processing capabilities further allow operators to manage shipments more efficiently, ensuring timely and reliable service for their customers.

K36 Therapeutics

Series B in 2023
K36 Therapeutics develops small molecule therapeutics for cancer treatment. It translates epigenetic modulation of oncogenic pathways into small molecule therapies.

SAFE Security

Series B in 2023
SAFE Security, also known as Lucideus Tech Private Limited, is a cyber risk management company headquartered in New Delhi, India. Founded in 2012, it specializes in providing comprehensive information technology risk assessment and digital security services to organizations globally. The company develops a cyber risk quantification and management platform that enables businesses to continuously monitor and respond to cyber threats in real time. SAFE Security's offerings include IT security maturity assessments, governance policy formation, application security, IT infrastructure security, and emergency response services. By establishing a common risk taxonomy, the platform facilitates better communication among stakeholders and shifts the focus of security discussions from tactical projects to strategic value, ultimately helping organizations mitigate cyber risks through prioritized actionable insights.

Canoe

Series B in 2023
Canoe Software Inc. provides a sophisticated software solution focused on financial document and data management. Founded in 2013 and based in New York, the company specializes in automating the extraction and organization of investment documents using artificial intelligence and machine learning technologies. This enables users to efficiently convert unstructured data from various formats, such as PDFs, into actionable insights, thereby improving operational efficiency. Canoe's platform supports a wide range of clients, including single and multi-family offices, endowments, foundations, pensions, investment consultants, and financial institutions, facilitating better management of post-investment operations, monitoring, and reporting. By streamlining the data management process, Canoe helps minimize manual data entry and enhances the accuracy of financial reporting and analysis.

NOCD

Series B in 2023
NOCD Inc. is a Chicago-based company founded in 2014 that specializes in developing a mobile application aimed at assisting individuals with obsessive-compulsive disorder (OCD). The platform connects users to licensed therapists who specialize in OCD through face-to-face video therapy sessions. Utilizing cognitive behavioral therapy techniques, the application guides users in self-treatment and monitoring of their symptoms, offering tools for exposure and response prevention exercises. In addition to therapy sessions, NOCD provides 24/7 support via self-help resources and peer communities, facilitating ongoing care and enabling patients to manage their condition effectively. The company focuses on improving treatment outcomes for OCD through its innovative online platform.

MEIHUAMEDICAL

Series B in 2022
MEIHUAMEDICAL develops, produces and sells microbial medical instruments & diagnostic reagents.

Kaiko

Series B in 2022
Kaiko is a leading provider of cryptocurrency market data, offering global connectivity to over 100 centralized and decentralized exchanges. It bridges traditional finance with crypto by delivering actionable financial data through its Market Data, Quantitative Analytics, Indices, and Research units.

EurekaBio

Series B in 2022
EurekaBio specializes in developing solutions for cancer immunotherapy, particularly in the realm of cell therapy. The company offers automated manufacturing equipment for cell therapies and a platform for vector production. By focusing on automation in medical equipment related to gene and cell therapy, EurekaBio aims to enhance the accuracy and efficiency of cancer treatments, ultimately benefiting patients in need of innovative therapeutic options.

Invetx

Series B in 2022
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.

ekincare

Series B in 2022
ekincare is an AI-powered integrated health benefits platform that provides personalized healthcare solutions for organizations and employees. It offers a range of services including online consultations, health check-ups, medicine delivery, wellness programs, and fitness services.

Inceptio Technology

Series B in 2022
Inceptio Technology is a developer of autonomous driving heavy-duty trucks based in Shanghai, China, with additional research and development centers in Silicon Valley. Founded in 2018, the company aims to transform line-haul logistics by offering a nationwide freight network that enhances safety, efficiency, and cost-effectiveness for logistic customers. Its autonomous trucks leverage advanced artificial intelligence, new energy technology, and logistics big data to deliver innovative and reliable transportation solutions. By focusing on the integration of these technologies, Inceptio Technology is positioned to provide significant improvements in the logistics sector.

Saas Labs

Series B in 2022
SaaS Labs is a developer of cloud-based solutions focused on enhancing communication and marketing efficiency for businesses. Their primary product is a phone system that allows users to make and receive calls from a computer, web browser, or desktop, facilitating seamless communication from any location. The system enables users to acquire virtual phone numbers in various countries and start making calls or sending texts within minutes. Additionally, it offers features for setting up call centers, tracking calls, and accessing call recordings, all of which contribute to improved productivity for sales teams. Beyond communication tools, SaaS Labs also develops marketing products aimed at increasing brand visibility.

Mention Me

Series B in 2022
Mention Me is a London-based software-as-a-service platform, founded in 2013, that helps online businesses run refer-a-friend programs. The platform enables customers to refer brands to friends via email or social media, rewarding both the referrer and the referred customer, and supports social sharing and name sharing to capture real-world conversations. It provides offers tailored to different customers, cohort-based A/B testing for campaign optimization, and integrates with e-commerce platforms and tag containers to synchronize referral data with core systems. Real-time results are shown through a referral dashboard, with ongoing performance reviews and best-practice guidance for merchants seeking new customer acquisition and growth through word-of-mouth marketing.

Juro

Series B in 2022
Juro develops an AI-enabled contract automation platform for legal and business teams that lets users create, negotiate, execute, and manage contracts directly in a browser. The platform uses machine learning and natural language processing to automate contract creation and workflow, integrates with existing business systems, and aims to speed up contract cycles up to tenfold compared with traditional tools. It serves a global base of customers, supporting thousands of agreements across many industries and countries.

Thinksurance

Funding Round in 2022
Thinksurance operates an online platform that connects business insurance providers with clients. It offers services such as insurance comparison, consultation, needs analysis, and risk assessment for commercial and industrial insurance. The company also provides additional services like factoring and damage report assistance.

Leocare

Series B in 2021
Leocare Assurance is an insurance company that provides a range of multi-equipment contracts, focusing on the design, distribution, and management of various insurance products. Its platform caters to clients by offering insurance solutions for auto and housing needs, as well as digital assets. By combining protection with savings, Leocare aims to meet the diverse requirements of its customers while ensuring a seamless experience in managing their insurance products.

Lighthouse

Series B in 2021
Lighthouse is a commercial platform tailored for the travel and hospitality industry, specializing in hotel management solutions. The company offers a cloud-based platform that visualizes and leverages data to enhance business success. By providing actionable market insights and business intelligence tools, Lighthouse enables hoteliers and hotel management companies to make informed revenue and distribution decisions. Its services include real-time data analytics, which empower users to maximize property occupancy rates and increase revenue and profit. Formerly known as OTA Insight, Lighthouse aims to transform complex market dynamics into manageable strategies that foster growth in the hospitality sector.

TenaFe

Series B in 2021
TenaFe develops SSD controller technology for data storage solutions across client devices, data centers, and emerging edge environments. Based in Campbell, California, the company relies on patented technology to deliver reliability, performance, and energy-efficient SSDs for devices ranging from connected gadgets to personal computers and data centers, enabling improved storage reliability and energy efficiency.

OriGynMED

Series B in 2021
OriGynMED provides deep professional resources for the invested companies through its global ecosystem to help the business development of the companies. It is a technology-based medical company.

LeadIQ

Series B in 2021
LeadIQ develops a sales prospecting automation platform that streamlines lead management processes. Its key products include Prospector (for searching prospects on LinkedIn and other websites), Scout (for finding contact information), and personal intelligence APIs (for comprehensive profile searches). LeadIQ integrates with various data sources to enrich profiles, enabling sales teams to focus on qualified leads and close deals more efficiently.

Jiffy.ai

Venture Round in 2021
Jiffy.ai is an AI-powered software company that automates tasks for modern digital enterprises. Its intelligent robots adapt to changes, enabling businesses to optimize staff productivity by handling critical yet low-value tasks. The platform processes unstructured data and employs NLP and ML algorithms, achieving high automation rates of up to 90%.

NOCD

Series B in 2021
NOCD Inc. is a Chicago-based company founded in 2014 that specializes in developing a mobile application aimed at assisting individuals with obsessive-compulsive disorder (OCD). The platform connects users to licensed therapists who specialize in OCD through face-to-face video therapy sessions. Utilizing cognitive behavioral therapy techniques, the application guides users in self-treatment and monitoring of their symptoms, offering tools for exposure and response prevention exercises. In addition to therapy sessions, NOCD provides 24/7 support via self-help resources and peer communities, facilitating ongoing care and enabling patients to manage their condition effectively. The company focuses on improving treatment outcomes for OCD through its innovative online platform.

GYENNO Technologies

Series B in 2021
GYENNO Technologies is a digital health company developing medical devices for people with disabilities. GYENNO's products include GYENNO spoon, which helps people with hand tremors eat without stress, and the GYENNO matrix, a wearable motion and gait quantitative evaluation system for Parkinson's disease.

Innovusion

Series B in 2021
Innovusion, founded in 2016 and based in Sunnyvale, California, specializes in developing autonomous driving perception systems. The company is renowned for its image-grade LiDAR sensor systems, which are designed to meet the rigorous demands of level 4 and 5 autonomous vehicles as well as Advanced Driver Assistance Systems (ADAS). Innovusion's products stand out due to their combination of long range, high resolution, hardware-accelerated sensor fusion, compact design, ease of integration, and cost-effectiveness.

Toothsi

Series B in 2021
Toothsi is a dental company that offers clear aligners, an alternative to traditional braces, to gradually shift teeth into proper alignment. Toothsi's aligners are removable, invisible, and more comfortable than metal braces. Toothsi also provides oral hygiene products, teeth whitening solutions, and aligner accessories for complete oral care.

Inceptio Technology

Series B in 2021
Inceptio Technology is a developer of autonomous driving heavy-duty trucks based in Shanghai, China, with additional research and development centers in Silicon Valley. Founded in 2018, the company aims to transform line-haul logistics by offering a nationwide freight network that enhances safety, efficiency, and cost-effectiveness for logistic customers. Its autonomous trucks leverage advanced artificial intelligence, new energy technology, and logistics big data to deliver innovative and reliable transportation solutions. By focusing on the integration of these technologies, Inceptio Technology is positioned to provide significant improvements in the logistics sector.

Blueglass Yogurt

Series B in 2021
Blueglass Yogurt is a food and beverage brand based in China that specializes in a diverse range of yogurt-based products. The company offers an extensive selection, including signature fancy yogurt, fruit yogurt, yogurt salads, cakes, pastries, drinks, and ice cream. By owning and operating its stores, Blueglass Yogurt ensures that customers have access to freshly made yogurt, enhancing the overall consumer experience. The brand aims to cater to the growing demand for fresh and innovative yogurt products among domestic consumers.

Castor

Series B in 2021
Castor is an international health-tech company that provides a cloud-based clinical data platform designed to streamline the clinical trial process for researchers globally. Founded by CEO Derk Arts, MD, Ph.D., the platform is utilized by over 50,000 researchers in 90 countries, supporting more than 4,000 studies across diverse therapeutic areas, including diabetes, cardiovascular disease, rare diseases, infectious diseases, and oncology. Castor's platform facilitates the collection and analysis of extensive data from both traditional and remote trials, having reached significant milestones such as 180 million data points and 2 million enrolled patients. The company's mission is to make research data reusable, thereby enabling AI-driven clinical trials and enhancing the overall impact of data within the medical research community.

Quizizz

Series B in 2021
Quizizz Inc. is an educational technology company based in Palo Alto, California, founded in 2015. It offers a mobile application that enables users to create, generate, and assess quizzes, fostering an interactive learning environment. The platform is designed for teachers, students, and parents, allowing them to engage in multiplayer classroom activities and assessments. Quizizz provides gamified quizzes and interactive lessons that can be utilized on any device, either in-person or remotely. The application facilitates quick assessments across various topics, eliminating the need for manual grading and delivering instant analytics. With over 20 million users monthly, Quizizz supports learning in schools, homes, and workplaces worldwide.

Patient 21

Series B in 2021
Patient21 operates a health platform focused on improving the doctor-patient connection, which they view as essential for effective healthcare. The company aims to modernize the healthcare experience by addressing the fragmented and outdated processes currently prevalent in the industry. By leveraging technology, Patient21 enhances dental clinics with management software that streamlines administrative tasks such as appointment scheduling and patient data management. They also provide electronic health records (EHR) to healthcare professionals, which helps improve diagnostic quality and reduce costs. Through these innovations, Patient21 seeks to facilitate better decision-making for both patients and physicians, ultimately promoting a more personalized and collaborative approach to healthcare.

Smol

Series B in 2021
Smol is a homecare startup specializing in the delivery of eco-friendly laundry capsules and dishwasher tablets directly to customers' homes via subscription. The company's products are designed to fit through standard letterboxes, offering convenience and cost savings compared to leading brands. Smol's offerings are vegan-friendly, free from animal testing and derivatives, and packaged in recycled and recyclable materials, aligning with environmentally conscious consumer preferences.

Proximie

Series B in 2021
Proximie is a health technology company that enables surgeons worldwide to collaborate remotely using augmented reality, artificial intelligence, and machine learning. Its platform allows surgeons to visually guide complex surgeries, democratizing access to advanced surgical knowledge.

B-One

Series B in 2021
B-One Ortho Corp. is a manufacturer of orthopedic healthcare solutions, specializing in artificial joints that facilitate joint replacement surgeries. Founded in 2015 and headquartered in Cedar Knolls, New Jersey, the company also maintains offices in Shanghai and Suzhou, China. Its notable products include the B-One total hip system, which features advanced coating technology and instrumentation, as well as the Juveno bone-conserving femoral prosthesis and primary acetabular systems. These innovations aim to enhance the effectiveness of hip and knee arthroplasty, ultimately helping patients regain their mobility and improve their quality of life.

OZiva

Series B in 2021
OZiva is a plant-based clean nutrition brand that specializes in producing organic nutritional products aimed at promoting healthier lifestyle choices. The company offers a diverse range of items, including those focused on fitness, hair and skin health, and both men's and women's wellness. OZiva distinguishes itself by integrating ancient Ayurvedic principles with modern micronutrient science, creating a comprehensive nutrition and fitness ecosystem. This approach not only addresses everyday nutritional needs but also fosters a supportive digital community for individuals pursuing healthier living. Through its offerings, OZiva aims to make healthy dietary planning convenient and accessible for its customers.

Innovusion

Series B in 2021
Innovusion, founded in 2016 and based in Sunnyvale, California, specializes in developing autonomous driving perception systems. The company is renowned for its image-grade LiDAR sensor systems, which are designed to meet the rigorous demands of level 4 and 5 autonomous vehicles as well as Advanced Driver Assistance Systems (ADAS). Innovusion's products stand out due to their combination of long range, high resolution, hardware-accelerated sensor fusion, compact design, ease of integration, and cost-effectiveness.

LakeShore Biopharma

Series B in 2021
Yisheng Biopharma Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and marketing of immuno-oncology products and vaccines. Founded in 2002 and headquartered in Beijing, the company operates in China, the United States, Cambodia, and Singapore. Yisheng Biopharma utilizes its novel PIKA immunomodulating technology to enhance immune responses against cancers and infectious diseases. Key products under development include YS-ON-001, an investigational therapy aimed at treating advanced solid tumors, as well as YS-HBV-001, a vaccine for hepatitis B, and a PIKA-based rabies vaccine designed for rapid protection against rabies infection. The company's innovative approach targets multiple immune pathways to improve treatment outcomes.

Metcela

Series B in 2021
Metcela is a clinical-stage biotechnology company based in Kawasaki, Japan, developing fibroblast-based therapies for heart disease. Its approach uses VCAM-1–positive cardiac fibroblasts derived from a patient’s own heart to repair damaged tissue and reestablish a supportive microenvironment, rather than replacing cells. The lead program, MTC001, aims to restore heart function by promoting natural healing in preclinical studies. Metcela was founded in 2016.

OriGynMED

Series B in 2020
OriGynMED provides deep professional resources for the invested companies through its global ecosystem to help the business development of the companies. It is a technology-based medical company.

HiBob

Series B in 2020
Founded in 2015, HiBob develops Bob, an intuitive cloud-based HR management system designed for global, remote, and collaborative work environments. Bob empowers employees, fosters company culture, and maximizes employee experience through tools for time management, performance tracking, attendance records, compensation management, and more. Over 1,000 modern companies worldwide rely on Bob to drive organizational success.

Tibber

Series B in 2020
Founded in Norway and Sweden in 2016, Tibber is a digital electricity supplier offering smart solutions to minimize customers' consumption and costs. It provides renewable energy at fair prices, real-time analytics via its app, and compatibility with various smart home devices. Tibber aims to reduce residential electricity consumption by 20% across Europe.

Odaseva

Series B in 2020
Odaseva is a company specializing in data management solutions for large enterprises utilizing Salesforce. It offers a comprehensive cloud-based platform that focuses on data protection, privacy, and governance. The Odaseva Enterprise Data Security Platform is designed to ensure the confidentiality, integrity, and availability of critical business information by providing integrated security products and services. Key features of the platform include backup and recovery, archiving, monitoring of governor limits, and compliance support for regulations such as GDPR. By enabling businesses to take full control of their data, Odaseva helps eliminate risks and facilitates confident digital transformation.

Planck

Series B in 2020
Planck is a commercial insurance data platform that enhances the underwriting process for insurers through advanced technology and artificial intelligence. The platform aggregates extensive datasets to provide real-time analytics and insights, streamlining the assessment of risks associated with businesses. By automating the completion of ACORD forms and leveraging publicly available data, image processing, and company reports, Planck facilitates accurate and efficient underwriting. This approach minimizes the potential for fraud and errors, ultimately helping insurance providers to develop tailored policies and reduce loss ratios. Through its innovative solutions, Planck aims to transform the way insurance companies evaluate and underwrite risks in the commercial sector.

Medallia Digital Experience Analytics

Series B in 2020
Decibel Insight Limited offers an online platform designed to analyze user behavior on websites and applications, helping enterprise businesses enhance the customer experience at various digital touchpoints. The company utilizes machine learning technology to process a wide array of behavioral metrics, such as mouse movements and error occurrences, providing insights through features like heatmaps, session replays, form analytics, and detailed performance reports. Decibel's solutions, available both on-premise and as Software as a Service (SaaS), cater to industries including eCommerce, finance, media, and travel. Established in 2013 and headquartered in London, with additional offices in Denver and Boston, Decibel serves major brands like Lego, General Motors, and British Airways, enabling them to identify opportunities for improvement and foster a customer-centric approach within their organizations.

Otrium

Series B in 2020
Otrium is an innovative online platform that addresses the issue of unsold inventory in the fashion industry by providing a marketplace for discounted clothing. The company has established partnerships with over 300 brands, including emerging designers and luxury names, catering to more than 3 million shopping members. Otrium's shop-in-shop outlet model offers a diverse selection of fashion items for both men and women, allowing customers to access the latest trends at competitive prices. The platform enhances the shopping experience with services such as next-day delivery and efficient return processes, making it a convenient option for consumers seeking quality fashion at reduced rates.

Fenbeitong

Series B in 2020
Fenbeitong is a company that provides an enterprise consumption platform designed to enhance control over corporate expenditures. By utilizing intelligent control rules and reminder mechanisms, Fenbeitong enables businesses to significantly reduce costs associated with travel, vehicle usage, procurement, and other public consumption activities. The platform offers a corporate wallet application that facilitates the management, payment, and reimbursement of corporate expenses, allowing employees to avoid upfront costs and cumbersome reimbursement processes. Additionally, Fenbeitong supports a credit monthly payment system and a unified invoice approach, which streamlines financial operations and boosts overall business efficiency.

Funnel

Series B in 2020
Founded in 2014 by Fredrik Skantze and Per Made, Funnel is a software company specializing in marketing analytics. It integrates with over 400 data sources to automate data collection from various advertising platforms, catering to e-commerce companies, media agencies, brands, B2B businesses, mobile apps, and gaming companies.

Oviva

Series B in 2020
Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.

Gloat

Series B in 2019
Gloat is an innovative Internal Talent Marketplace that empowers organizations to unlock and utilize the hidden potential of their workforce. Through its AI-driven platform, Gloat matches employees' skills and aspirations with suitable internal career opportunities, fostering personalized career development in real time while maintaining user anonymity. This approach not only supports individual career growth but also enhances organizational agility and visibility. Gloat is utilized by prominent companies around the globe, with deployments in over 120 countries, including major brands such as Unilever, PepsiCo, and HSBC. By providing valuable insights and data-driven recommendations, Gloat enables individuals to make informed career decisions and helps managers identify the right candidates for various roles within their organizations.

CredR

Series B in 2019
CredR is an Indian online platform specializing in the trade of verified and certified pre-owned two-wheeler vehicles. It employs dynamic pricing algorithms and offers after-sales services, aiming to streamline the buying and selling process for users.

ForceClouds

Series B in 2019
ForceClouds is a developer of enterprise software designed to enhance information automation in a simple, safe, efficient, and compliant manner. The company focuses on providing custom integration capabilities that streamline various processes, including sales management, clinical trials, and the management of big data and artificial intelligence. By enabling large life sciences companies to harness actionable insights from their process data, ForceClouds aims to improve operational efficiency and decision-making within the industry.

Medallia Digital Experience Analytics

Series B in 2019
Decibel Insight Limited offers an online platform designed to analyze user behavior on websites and applications, helping enterprise businesses enhance the customer experience at various digital touchpoints. The company utilizes machine learning technology to process a wide array of behavioral metrics, such as mouse movements and error occurrences, providing insights through features like heatmaps, session replays, form analytics, and detailed performance reports. Decibel's solutions, available both on-premise and as Software as a Service (SaaS), cater to industries including eCommerce, finance, media, and travel. Established in 2013 and headquartered in London, with additional offices in Denver and Boston, Decibel serves major brands like Lego, General Motors, and British Airways, enabling them to identify opportunities for improvement and foster a customer-centric approach within their organizations.

Hedone

Series B in 2019
Hedone is a company based in Shanghai, China, operating an e-commerce platform specializing in beauty and makeup products. Founded in 2014, Hedone caters primarily to Chinese millennials, offering a range of fashion and beauty items designed to embrace individuality.

Thinksurance

Series B in 2019
Thinksurance operates an online platform that connects business insurance providers with clients. It offers services such as insurance comparison, consultation, needs analysis, and risk assessment for commercial and industrial insurance. The company also provides additional services like factoring and damage report assistance.

CareStack

Series B in 2019
CareStack is a company that provides an all-in-one cloud-based platform designed to streamline dental practice management. The platform integrates various functionalities including patient engagement, scheduling, telehealth conferencing, charting, automated reminders, claims and billing, and business insights. This comprehensive solution aims to enhance operational efficiency, improve patient care, and increase financial success for dental practices. CareStack's mission is to support dentists in achieving better practice management and an improved quality of life through its technology-driven offerings.

Insilico Medicine

Series B in 2019
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Spendesk

Series B in 2019
Spendesk is an innovative expense management platform founded in 2016 that aims to streamline the spending process for businesses. It provides an all-in-one solution that includes features such as spend approvals, corporate cards, expense reimbursements, budget tracking, and invoice management, all designed to enhance visibility and automate financial workflows. This platform is particularly beneficial for finance teams, allowing them to save time and allocate resources toward more strategic initiatives. Trusted by a diverse range of organizations, from startups to established brands like Algolia and Soundcloud, Spendesk helps users focus on their core business operations rather than administrative tasks. Additionally, Spendesk supports a community of finance leaders through its initiative, CFO Connect, which has grown rapidly to include over 7,000 members.

Aperza

Series B in 2019
Aperza Inc. is a company that develops and operates various online platforms aimed at enhancing the manufacturing industry. Founded in 2016 and based in Yokohama, Japan, Aperza offers a range of services including an industrial portal, an industrial catalog portal, and an e-commerce marketplace tailored for industrial products. The company focuses on facilitating connections between engineers and manufacturers, enabling easy access to price comparisons and the purchasing of raw materials. Additionally, Aperza provides media outlets such as Monozukuri News and Automation News Web, which cover relevant industry topics. By addressing barriers related to information, transactions, and communication, Aperza aims to support the evolution of the manufacturing sector, including initiatives related to Industry 4.0 and smart factory innovations, ultimately contributing to the industry's growth and modernization.

StashAway

Series B in 2019
StashAway Malaysia Sdn Bhd is a licensed investment platform in Malaysia that specializes in wealth management and portfolio management for both retail and accredited investors. The company is dedicated to providing accessible investment solutions, emphasizing low fees and personalized financial planning. StashAway's platform caters to a diverse audience by offering tools and resources that facilitate informed investment decisions. Its innovative investment strategy, ERAA® (Economic Regime-based Asset Allocation), aims to maximize long-term returns while managing individual risk exposure in response to changing economic conditions. Through its user-friendly mobile app, StashAway simplifies the investment process, making wealth management more approachable for a broad range of investors.

Nanos Medical

Series B in 2019
Nanos Medical specializes in the research, development, manufacturing, and sales of disposable medical devices, primarily targeting the cardiovascular and ear, nose, and throat (ENT) fields. The company offers a range of innovative products, including sinus balloon catheters, eustachian tube balloons, disposable nasopharyngeal airways, nasolacrimal balloons, and drug-eluting stents for sinus applications. Through its advanced medical devices, Nanos Medical aims to enhance treatment options for hospitals and patients, contributing to improved healthcare outcomes.

Whatfix

Series B in 2019
Whatfix provides a digital adoption platform that enhances user productivity, ensures process compliance, and improves user experience across various applications. It offers simulated application environments for training and no-code application analytics.

Beam Therapeutics

Series B in 2019
Beam Therapeutics is a biotechnology company developing precision genetic medicines using its proprietary base editing technology. Its focus includes therapies for hematological and genetic diseases, with ongoing programs targeting sickle cell disease, alpha-1 antitrypsin deficiency, and other serious conditions.

LenoMed Medical

Series B in 2018
LenoMed Medical is a manufacturer of medical devices focused on improving diabetes management. With over 15 years of research and development experience in infusion technology, the company specializes in creating innovative products such as the InnoTech insulin pump, drug infusion pumps, and related disposables. LenoMed is dedicated to enhancing diabetes care through the integration of continuous glucose monitoring technology with their insulin pumps, aiming to provide patients with better treatment options and monitoring capabilities. Their commitment to advancing diabetes management is reflected in their comprehensive diabetes care management system.

JuLive.com

Series B in 2018
Julive is a new house transaction service platform.

Axoni

Series B in 2018
Axoni is a technology company specializing in real-time data replication solutions tailored for the financial industry. Established in 2017, it focuses on serving major financial institutions, including banks, asset managers, hedge funds, and market infrastructure firms worldwide, with offices located in New York and London. The company's platform facilitates the rapid and reliable deployment of critical financial networks, ensuring automated, real-time data replication among market participants. Additionally, Axoni develops distributed ledger software that integrates traditional financial technologies with blockchain capabilities, enhancing market information, trend analysis, and communication networks. This innovative approach allows financial entities to modernize their systems related to legal records, lifecycle events, and cash flow calculations, thereby improving operational efficiency and data management.

Worktile Technology

Series B in 2018
Worktile Technology, established in 2013, is a Chinese software company headquartered in Beijing, with offices in Shanghai, Shenzhen, and Xi'an. It specializes in a web and mobile-based project management tool, designed to enhance team collaboration and productivity among developers and professionals. The platform facilitates task management, communication, and document sharing, aiming to streamline work processes and improve overall enterprise efficiency.

UWinTech

Series B in 2018
UWinTech is a provider of comprehensive IT operations and maintenance solutions based in Shenzhen, China. Founded in 2015, the company offers a range of services including EasyCMDB for configuration management, Easydevops for DevOps practices, Easyobserve for monitoring, EasyMAbuilder for automation, and Easyautoops for operational efficiency. UWinTech's services are designed to help enterprises reduce efforts and maximize productivity by covering continuous delivery, continuous deployment, operation automation, and application monitoring.

Moneybox

Series B in 2018
Moneybox is a mobile app facilitating saving, investing, and managing pensions. It encourages users to save spare change from daily spending for future investments.

Kyligence

Series B in 2018
Kyligence Inc. specializes in big data analytics, offering an intelligent data platform that simplifies analysis from on-premises to cloud environments. Its flagship product is the Kyligence Analytics Platform, providing sub-second query latency and simplified analytics for business users. Additionally, it offers KyBot for monitoring and optimizing performance, and Apache Kylin, an open-source distributed analytics engine supporting large datasets.

Kongming

Series B in 2018
Kongming Inc. is a Beijing-based company established in 2010 that specializes in social media technology and marketing solutions. It offers a range of products and services, including social monitoring tools, customer relationship management (CRM) systems, social networking advertising, and data analysis services. By leveraging these capabilities, Kongming aims to enhance client interactions and optimize marketing strategies within the social media landscape.

Fuse Universal

Series B in 2018
Fuse Universal, established in 2008, is a London-based company with offices in Sydney and Cape Town. It specializes in providing a social learning platform for large corporations, including FTSE 100 and Fortune 500 companies. The platform facilitates knowledge sharing, communication, and skill development via desktops and mobile devices. Fuse Universal serves over 150 global organizations, such as Hilti, Vodafone, and Panasonic, by fostering active engagement and deeper learning experiences through creativity and storytelling.

Red Points

Series B in 2018
Red Points is a technology company based in Barcelona, Spain, that specializes in online brand protection. Founded in 2011, the company offers a software-as-a-service platform designed to combat online counterfeiting, digital piracy, and distribution fraud. Utilizing advanced machine learning and computer vision techniques, Red Points' software effectively detects and removes counterfeit goods and pirated content from the internet. The platform operates across more than one hundred online marketplaces and social networks, addressing hundreds of thousands of incidents each month. With a client base that includes over five hundred brands worldwide, such as Bang & Olufsen, MVMT, and DOPE, Red Points provides essential solutions for brands and content owners seeking to safeguard their intellectual property rights in the digital landscape.

Tempest Therapeutics

Series B in 2018
Tempest Therapeutics Inc. is a biotechnology company based in South San Francisco, California, focused on developing small molecule therapeutics for cancer treatment. Established in 2011, the company aims to enhance anti-tumor immunity through its innovative drug pipeline, which includes clinical-stage candidates such as TPST-8844, TPST-1120, and TPST-1495. TPST-8844 targets an enzyme that helps tumor cells evade immune responses, while TPST-1120 blocks the PPAR-alpha pathway to stimulate immune effector cells essential for fighting tumors. Additionally, the company's therapeutics address pathways that directly kill tumor cells and activate tumor-specific immunity, positioning Tempest Therapeutics at the forefront of cancer treatment innovation.

Duco Technology

Series B in 2018
Duco Technology Limited is a data engineering technology company that specializes in developing software for data matching, reconciliation, and transformation. Its primary offering is Duco Cube, a cloud-based, no-code platform that empowers users to normalize, validate, and reconcile various types of data on demand, thereby enhancing data integrity and analytics. The company serves a diverse range of clients, including international banks, asset managers, hedge funds, exchanges, and corporate service providers. Founded in 2006 and headquartered in London, Duco has expanded its presence with additional offices in New York, Wroclaw, Luxembourg, Edinburgh, and Singapore. By providing a flexible solution that integrates with existing systems, Duco enables financial institutions to improve business agility, reduce risks, and maintain compliance with regulations, all while minimizing disruption to their IT architecture.

Fibe

Series B in 2018
Fibe is an Indian consumer lending platform and app that serves young, aspirational, tech-savvy borrowers. It offers a range of financing options, including cash and personal loans, loans against mutual funds, salary advances, educational, medical, and solar loans, and credit cards. The platform provides tools such as credit scores, financial wellness resources, and loan eligibility calculators to help customers plan and access financing during crunch times.

Orient Speech Therapy

Series B in 2017
Orient Speech Therapy Center specializes in providing professional speech and language therapy services for children facing communication challenges, including those with autism or speech disorders. The center focuses on the early screening, clinical diagnosis, and therapeutic interventions essential for improving children's speech and social skills. It offers a range of refined curricula designed specifically for young learners, including the Star Curriculum, phonics and oral muscle courses, expression courses, and exercise classes. Through these structured programs, Orient Speech Therapy Center aims to enhance the communicative abilities of children, enabling them to express themselves more effectively and engage socially.

Candee

Series B in 2017
Candee Inc. is a Tokyo-based production company founded in 2015 that specializes in online video production and talent management. The company provides a range of services, including advertising, video editing, branding, content creation, public relations, and digital marketing. Through its online platform, Candee produces advertising and media videos, focusing particularly on mobile content, which allows businesses to effectively advertise and manage talent in the digital space.

Semma Therapeutics

Series B in 2017
Semma Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative cell therapies for patients with Type 1 diabetes. Founded in 2014, the company is dedicated to creating a transformative treatment that addresses the need for insulin injections by generating functional, insulin-producing beta cells through a proprietary method licensed from the laboratory of Professor Douglas Melton. Semma Therapeutics aims to combine these engineered cells with advanced devices to offer a potential replacement for the missing beta cells in diabetic patients, eliminating the need for immunosuppression. The company's ongoing research seeks to bring this novel therapeutic option to clinical settings, ultimately improving the lives of individuals living with diabetes.

Stockpile

Series B in 2017
Founded in 2010, Stockpile is a San Francisco-based financial services company that aims to democratize investing. It offers zero-fee trading, custodial accounts, gift cards, and fractional investing, enabling users to own stocks and cryptocurrencies with ease. The platform has been featured in prominent publications and maintains a high app store rating.

Haici Technology

Series B in 2017
Haici Technology is a developer of a SaaS-based mobile healthcare service platform aimed at enhancing hospital operations. The company focuses on improving the efficiency of hospital visits, reducing patient wait times, and expanding the range of services offered by healthcare institutions. Its platform integrates online and offline medical services, facilitating better connections between hospitals and patients. By optimizing the patient experience and streamlining administrative workflows, Haici Technology supports hospitals in delivering more effective and efficient healthcare services.

Chai Point

Series B in 2017
Chai Point is an omni-channel beverage brand in India focused on chai, using fresh, natural ingredients. It sells a range of hot and iced chai, shakes, and assorted tea snacks, and is expanding its coffee options. Operating in eight cities, it offers varieties of tea made from good-quality leaves with no artificial colors or flavors. The portfolio includes snacks such as multigrain biscuits, cake rusk, and quinoa puffs, and customers can order tea online for delivery, integrating store-based and digital channels.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.